BDNF and Cognitive impairment: Moreover, last studies show that treatment with SGLT2i (especially empagliflozin) may have a beneficial effect on cerebral BDNF, a key protein promoting memory and survival of neurons, consequently inhibiting the progression of cognitive disorders (Abdelgadir et al. 2018; Lin et al. 2014, Pawlos et al.2021).